CONNECT WITH US
HealthTech

HealthTech

Ascensia leads $36M funding round for glucose sensor startup

MedTech Dive logo

Published on

Add as a preferred source on Google
Ascensia leads $36M funding round for glucose sensor startup

Ascensia also struck an exclusive sales agreement with Sava, which is making a wearable to continuously monitor glucose and other biomarkers.

Sava plans to use the funds to scale up manufacturing and prepare to sell its first product.

The company is developing a continuous glucose sensor that, like other CGMs, measures glucose in the interstitial fluid just beneath the skin. However, Sava claims its microsensors are about 10 times shorter than the filament used in most devices today, reducing disruption to the skin.

The company plans to start a pivotal trial this year, with the goal of launching the device in Europe after receiving a CE mark in the next two years. Sava intends for its sensor to be approved for non-adjunctive use, meaning it could be used for insulin dosing decisions without routine fingersticks to confirm.

Ascensia plans to start distributing Sava’s sensor in Europe. Ascensia, which makes diabetes supplies including blood glucose meters, test strips and lancets, said it has made a strategic equity investment in Sava, and that its microsensor technology has potential in the long term for health monitoring beyond glucose.

Ascensia previously struck a distribution agreement with another CGM maker, Senseonics, whose sensors can be implanted for up to a year. Senseonics recently reached an agreement with Ascensia to bring its commercial operations, including sales and marketing, in-house.

About 12 million people use CGMs today, just a fraction of adults globally with diabetes, according to Sava.

“The market is growing, but with just two manufacturers leading it, demand is outpacing choice for distributors, clinicians and patients,” Sava said in a statement.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.